THE PROCEDURE OF LYMPHOCYTOIMMUNOTHERAPY UNDER PRE-PREGNANCY MANAGEMENT OF WOMEN WITH RECURRENT MISCARRIAGE
- Authors: Krechetova LV1, Vtorushina VV1, Golubeva EL1, Agadzhanova AA1, Tetruashvili NK1
-
Affiliations:
- Federal State Budget Institution «Research Center for Obstetrics, Gynecology and Perinatology» Ministry of Healthcare of the Russian Federation
- Issue: Vol 14, No 1S (2017)
- Pages: 29-31
- Section: Articles
- URL: https://journals.rcsi.science/raj/article/view/120595
- DOI: https://doi.org/10.36691/RJA204
- ID: 120595
Cite item
Full Text
Full Text
##article.viewOnOriginalSite##About the authors
L V Krechetova
Federal State Budget Institution «Research Center for Obstetrics, Gynecology and Perinatology» Ministry of Healthcare of the Russian Federation
V V Vtorushina
Federal State Budget Institution «Research Center for Obstetrics, Gynecology and Perinatology» Ministry of Healthcare of the Russian Federation
E L Golubeva
Federal State Budget Institution «Research Center for Obstetrics, Gynecology and Perinatology» Ministry of Healthcare of the Russian Federation
A A Agadzhanova
Federal State Budget Institution «Research Center for Obstetrics, Gynecology and Perinatology» Ministry of Healthcare of the Russian Federation
N K Tetruashvili
Federal State Budget Institution «Research Center for Obstetrics, Gynecology and Perinatology» Ministry of Healthcare of the Russian Federation
References
- Saraswat L., Bhattacharya S., Maheshwari A., Bhattacharya S. Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review. BJOG. 2010 Feb;117(3):245-57.
- Oppenraaij R.H., Jauniaux E., Christiansen O.B., Horcajadas J.A., Farquharson R.G., Exalto N.; ESHRE Special Interest Group for Early Pregnancy (SIGEP). Predicting adverse obstetric outcome after early pregnancy events and complications: a review. Hum Reprod Update. 2009; 15(4): 409-21.
- Reccurent pregnancy loss: causes, controversies and treatment. Ed. by Carp Howard J.A.: Informa UK ltd.; 2007. 290p.
- Chong P.J., Matzner W.L., Ching W.T. Benefit of leukocyte immunizations? Fertil Steril. 1993; 59(1): 247-9.
- Chong P.J., Matzner W.L., Ching W.T. Controversy about immunotherapy. Fertil Steril. 1993; 59(5): 1138-9.
- Сидельникова В.М., Сухих Г.Т. Невынашивание беременности: Руководство для практикующих врачей. -М.: ООО «Медицинское информационное агенство», 2011.-516с.
- Сухих Г.Т., Л.В. Ванько. Иммунология беременности. М.: Изд-во РАМН; 2003. 400 с.
- Посиссева Л.В., Малышкина А.И., Бойко Е.Л., Сотникова Н.Ю., Перетятко Л.П., Фетисова И.Н. Реабилитация репродуктивного здоровья супружеских пар с невынашиванием беременности. Иваново: ОАО «Изд-во Иваново»; 2008. 240с.
- Петросян Л.А. Оптимизация лимфоцитоиммунотерапии в лечении привычной потери беременности первого триместра. Автореф.дисс.канд.мед наук, Москва. 2009. 24с.
- Khonina N.A., Broitman E.V., Shevela E.Y., Pasman N.M., Chernykh E.R. Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion. Arch Gynecol Obstet. 2013; 288(4): 933-7.
- Taro Nonaka, Koichi Takakuwa, Izumi Ooki, Mami Akashi, Tomokazu Yokoo, Akira Kikuchi, Kenichi Tanaka. Results of Immunotherapy for Patients with Unexplained Primary Recurrent Abortions - Prospective Non-Randomized Cohort Study. American Journal of Reproductive Immunology. 2007; 58: 530-36.
- Recurrent Miscarriage Immunotherapy Trialists Group. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol. 1994; 32(3): 255.
- Кречетова Л.В., Хачатрян Н.А., Тетруашвили Н.К., Вторушина В.В., Степанова Е.О., Голубева Е.Л., Николаева М.А., Сухих Г.Т. Динамика выработки антиотцовских антилейкоцитарных антител при иммунизации аллогенными клетками женщин с привычным выкидышем. Акушерство и гинекология, 2015; 3: 16-20.
